CMV DISRUPTION OF CONSTITUTIVE MHC CLASS II

CMV 破坏 MHC II 类结构

基本信息

  • 批准号:
    6690776
  • 负责人:
  • 金额:
    $ 25.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-01-01 至 2006-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (Verbatim from the applicant's abstract) Human cytomegalovirus (CMV) is a significant viral cause of morbidity and mortality in transplant recipients. In these patients CMV disease often results from reactivation of latent and persistent virus. A central mechanism of persistence is the ability of CMV to escape detection by host T lymphocyte-mediated immuno-surveillance, which is mediated by both CD8+ T lymphocytes and CD4+ T lymphocytes. In an analogous fashion to CMV encoding multiple genes which disrupt MHC class I, it now appears that CMV has developed mechanisms to evade CD4+ T lymphocyte mediated immuno-surveillance through disruption of MHC class II molecule expression. Within infected cells, CMV inhibits IFN-g induced MHC class II expression by mechanisms that disrupt the IFN-g signaling pathway. Recently the effect of CMV on MHC class II expression has been expanded to include inhibition of constitutively expressed class II, by its gene US2. Using a constitutive HLA class II expressing cell line, we have found a major CMV-mediated decrease in surface class II expression that is independent of US2 or proteasomal degradation. Our Northern, Western and confocal microscopy studies suggest that the mechanism is a defect in trafficking of mature class II to the cell surface. Moreover, this mechanism specifically targets class II, since studies with mutant CMV lacking the genes that alter class I demonstrate normal to increased class I expression, but decreased class II surface expression. Based on our preliminary data, we will test the hypothesis that CMV specifically blocks class II trafficking by altering the intracellular vesicle trafficking machinery. In Specific Aim I, we will further characterize the effect of CMV infection on MHC class II expression. The transport and assembly of MHC class II molecules in infected cells will be examined using co-immunoprecipitation, Western blot analyses, and confocal microscopy. In Specific Aim II, the mechanism(s) of the CMV-mediated decrease in constitutive MHC class II expression will be investigated, specifically examining the role of CMV-mediated disruption of the actin and microtubule networks in this inhibition. We will quantify the effect of CMV on the polymerization, cleavage and integrity of these structures and determine the mechanism(s) CMV uses to inhibit their ability to traffic class II positive vesicles. In Specific Aim III, stable transfections of the U373-CIITA line with CMV Towne strain cosmid clones will be used, in conjunction with a CMV cDNA library, to identify and isolate the CMV genes responsible for the decrease in constitutive MHC class II surface expression.
描述(摘自申请人摘要)人巨细胞病毒

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

William James Waldman其他文献

William James Waldman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('William James Waldman', 18)}}的其他基金

Endothelial-reactive antibodies: a diagnostic test for Susac's syndrome
内皮反应性抗体:苏萨克综合征的诊断测试
  • 批准号:
    8048660
  • 财政年份:
    2010
  • 资助金额:
    $ 25.81万
  • 项目类别:
Endothelial-reactive antibodies: a diagnostic test for Susac's syndrome
内皮反应性抗体:苏萨克综合征的诊断测试
  • 批准号:
    8133697
  • 财政年份:
    2010
  • 资助金额:
    $ 25.81万
  • 项目类别:
Antiviral activity of leflunomide against respiratory syncytial virus
来氟米特对呼吸道合胞病毒的抗病毒活性
  • 批准号:
    7908439
  • 财政年份:
    2009
  • 资助金额:
    $ 25.81万
  • 项目类别:
Antiviral activity of leflunomide against respiratory syncytial virus
来氟米特对呼吸道合胞病毒的抗病毒活性
  • 批准号:
    7679336
  • 财政年份:
    2008
  • 资助金额:
    $ 25.81万
  • 项目类别:
ANTIVIRAL ACTIVITY OF THE IMMUNOSUPPRESSANT LEFLUNOMIDE
免疫抑制剂来氟米特的抗病毒活性
  • 批准号:
    6708845
  • 财政年份:
    2001
  • 资助金额:
    $ 25.81万
  • 项目类别:
ANTIVIRAL ACTIVITY OF THE IMMUNOSUPPRESSANT LEFLUNOMIDE
免疫抑制剂来氟米特的抗病毒活性
  • 批准号:
    6287600
  • 财政年份:
    2001
  • 资助金额:
    $ 25.81万
  • 项目类别:
ANTIVIRAL ACTIVITY OF THE IMMUNOSUPPRESSANT LEFLUNOMIDE
免疫抑制剂来氟米特的抗病毒活性
  • 批准号:
    6632026
  • 财政年份:
    2001
  • 资助金额:
    $ 25.81万
  • 项目类别:
ANTIVIRAL ACTIVITY OF THE IMMUNOSUPPRESSANT LEFLUNOMIDE
免疫抑制剂来氟米特的抗病毒活性
  • 批准号:
    6510888
  • 财政年份:
    2001
  • 资助金额:
    $ 25.81万
  • 项目类别:
CMV DISRUPTION OF CONSTITUTIVE MHC CLASS II
CMV 破坏 MHC II 类结构
  • 批准号:
    6626385
  • 财政年份:
    2001
  • 资助金额:
    $ 25.81万
  • 项目类别:
CMV/IMMUNE INTERACTIONS IN TRANSPLANT ARTERIOSCLEROSIS
移植动脉硬化中巨细胞病毒/免疫相互作用
  • 批准号:
    6030747
  • 财政年份:
    1996
  • 资助金额:
    $ 25.81万
  • 项目类别:

相似海外基金

A novel motility system driven by two classes of bacterial actins MreB
由两类细菌肌动蛋白 MreB 驱动的新型运动系统
  • 批准号:
    22KJ2613
  • 财政年份:
    2023
  • 资助金额:
    $ 25.81万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
EGF Receptor Endocytosis: Mechanisms and Role in Signaling
EGF 受体内吞作用:机制及其在信号传导中的作用
  • 批准号:
    10552100
  • 财政年份:
    2023
  • 资助金额:
    $ 25.81万
  • 项目类别:
Mitochondrial positioning regulates redox-signaling during cell migration
线粒体定位调节细胞迁移过程中的氧化还原信号
  • 批准号:
    10520211
  • 财政年份:
    2023
  • 资助金额:
    $ 25.81万
  • 项目类别:
ROS Signaling in Wound Healing vs Tissue Repair
伤口愈合与组织修复中的 ROS 信号传导
  • 批准号:
    10654242
  • 财政年份:
    2023
  • 资助金额:
    $ 25.81万
  • 项目类别:
Pyroptotic Macrophages Traps Against Shigella Infection
焦亡巨噬细胞捕获志贺氏菌感染
  • 批准号:
    10646015
  • 财政年份:
    2023
  • 资助金额:
    $ 25.81万
  • 项目类别:
Converting cytoskeletal forces into biochemical signals
将细胞骨架力转化为生化信号
  • 批准号:
    10655891
  • 财政年份:
    2023
  • 资助金额:
    $ 25.81万
  • 项目类别:
Differential changes in energy metabolism in response to mechanical tension give rise to human scaring heterogeneity
响应机械张力的能量代谢的差异变化导致人类恐惧异质性
  • 批准号:
    10660416
  • 财政年份:
    2023
  • 资助金额:
    $ 25.81万
  • 项目类别:
Engineered tissue arrays to streamline deimmunized DMD gene therapy vectors
工程组织阵列可简化去免疫 DMD 基因治疗载体
  • 批准号:
    10724882
  • 财政年份:
    2023
  • 资助金额:
    $ 25.81万
  • 项目类别:
Basis and Function of Lateral Assembly of Cadherin Molecules in Adhesive Junctions of Humans and Model Organisms
人类和模型生物粘附连接中钙粘蛋白分子横向组装的基础和功能
  • 批准号:
    10715056
  • 财政年份:
    2023
  • 资助金额:
    $ 25.81万
  • 项目类别:
HIV particle morphology and biogenesis
HIV颗粒形态和生物发生
  • 批准号:
    10772748
  • 财政年份:
    2023
  • 资助金额:
    $ 25.81万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了